Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.3 (Omicron)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.16.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.372ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.372NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.425ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.425ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.425ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.425NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.144ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.54ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.54NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
N.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
N.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.1.15 (Gamma)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.1.15 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.15 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.15 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.348ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.348ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.348ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.348NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used